The Company anticipates continued profitability and positive cash flow, targeting operating income of 13% to 14% and Adjusted EBITDA of $12 to $14 million.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- Brainsway’s New Deep TMS Depression Study Completion: What Investors Should Watch Next
- BWAY Upcoming Earnings Report: What to Expect?
- BrainsWay Unveils Landmark Data on Accelerated Deep TMS for Depression
- Brainsway announces new data on noninvasive way to treat depression
- BrainsWay Takes Minority Stake in Canadian Mental Health Provider BrainStim Health